Results 171 to 180 of about 1,023,691 (284)

Moxibustion combinations for diabetic peripheral neuropathy: a network meta-analysis of 40 randomised trials. [PDF]

Front Endocrinol (Lausanne)
Du D, Wang S, Chen X, Wang J, Zhang X, Gao Y.   +5 more
europepmc   +1 more source

Initiation of SGLT2 Inhibitors Versus DPP‐4 Inhibitors in Metformin Users and Risk of Incident Depression: A Nationwide, Claims‐Based Active‐Comparator New‐User Study

Diabetes, Obesity and Metabolism, EarlyView.
ABSTRACT Aims To examine the association between initiation of sodium‐glucose cotransporter‐2 (SGLT2) inhibitors and risk of incident depression compared with dipeptidyl peptidase‐4 (DPP‐4) inhibitors among adults with newly diagnosed Type 2 diabetes receiving metformin.
Sangwoo Park, Seogsong Jeong, Hye Jun Kim, Dae Ho Lee, Soo Jung Choi, Sang Min Park   +5 more
wiley   +1 more source

Reproducibility of ACT, A simple-self-administered sCreening Tool for diabetic peripheral neuropathy. [PDF]

Front Neurol
Gad H, Elgassim E, Bennabhaktula S, Baraka A, Baagar K, Orszag A, Lovblom LE, Perkins BA, Malik RA.   +8 more
europepmc   +1 more source

First‐In‐Human Study of Mirogabalin (BM2216) Sustained‐Release Tablets: Safety, Tolerability, Pharmacokinetics, Food Effect and Dose Proportionality With Comparison to Mirogabalin Besylate in Healthy Participants

Diabetes, Obesity and Metabolism, EarlyView.
ABSTRACT Aim To characterise the pharmacokinetics (PKs) and safety of BM2216 sustained‐release (SR) tablets after single‐dose oral administration under fasted/fed conditions in healthy participants, assess the effect of food and dose proportionality, and compare the single and multiple‐dose PK of BM2216 SR tablets with mirogabalin besylate tablets to ...
Peiyang Song, Hongtao Zhao, Mingxue Zhu, Lei Wan, Yuan Chen, Zhongping Li, Chengyong Tang   +6 more
wiley   +1 more source

The association between the triglyceride-glucose index and diabetic peripheral neuropathy: a systematic review and meta-analysis. [PDF]

Front Endocrinol (Lausanne)
Gu X, Wei M, Wu C, Li A, Sun A, Guo J, Wang H, Wang C, Li Y, Zhu Q, Gong Y.   +10 more
europepmc   +1 more source

Longitudinal Metabolic Risk Factors Are Associated With Microvascular Complications

Diabetes, Obesity and Metabolism, EarlyView.
ABSTRACT Objective Determine associations between summaries of longitudinal metabolic risk factors and microvascular complications. Methods We performed a secondary analysis of participants with and without diabetes enrolled within the Atherosclerosis Risk in Communities Study that completed metabolic risk factors assessments four times across 11 years.
Cody H. Makinson, Jihyun Park, Eva L. Feldman, Brian C. Callaghan, Evan L. Reynolds   +4 more
wiley   +1 more source

Real world treatment patterns among patients with painful diabetic peripheral neuropathy in the United States. [PDF]

Pain Med
Schuster NM, Jeyakumar S, Menzie AM, Panni M, Princic N, Moynihan M, Argoff CE.   +6 more
europepmc   +1 more source

Oral Semaglutide in Routine Clinical Practice: 24‐Month Real‐World Effectiveness, Persistence and Safety in Adults With Type 2 Diabetes

Diabetes, Obesity and Metabolism, EarlyView.
ABSTRACT Aims Real‐world long‐term data on oral semaglutide are limited. We evaluated its 24‐month effectiveness, persistence, and safety in adults with type 2 diabetes (T2D). Materials and Methods This retrospective real‐world study included 232 adults with T2D initiating oral semaglutide at an Italian diabetes clinic.
Maria Pompea Antonia Baldassarre, Giulia Di Dalmazi, Federica Carrieri, Giorgia Centorame, Luigi Piacentino, Sara Coluzzi, Gloria Formoso   +6 more
wiley   +1 more source

Whole transcriptome sequencing and ceRNA regulatory network in diabetic peripheral neuropathy. [PDF]

Sci Rep
Yan Q, Zhang M, Xu LJ, Ma J, Wang J, Wang XM, Ma L.   +6 more
europepmc   +1 more source

Dapagliflozin Alters Plasma Metabolome in Patients With Type 1 Diabetes During Ketosis

Diabetes, Obesity and Metabolism, EarlyView.
ABSTRACT Aims Use of sodium‐glucose cotransporter 2 inhibitors (SGLT2i) in patients with type 1 diabetes (T1D) is limited by increased risk of ketoacidosis. We aimed to determine metabolic pathways affected by SGLT2i treatment in adults with T1D during ketosis induced by insulin withdrawal.
Rosa Yang, Kevin Cho, Max C. Petersen, Kai E. Jones, Gary J. Patti, Janet B. McGill, Samantha A. DiGruccio   +6 more
wiley   +1 more source